BreatheSuite is pleased to announce the findings of a recently study which demonstrated the usability effectiveness of the BreatheSuite MDI device and app. Our app was determined to be both clear & accessible for people using inhalers for the treatment of #asthma and #COPD, with the potential to improve their management of chronic lung diseases. This study examined 15 participants across a number of use case scenarios involving their metered-dose-inhalers (MDIs) and BreatheSuite's app and add-on. Our findings:

• All participants correctly completed a dose simulation using the Bluetooth device with no errors
• All participants were able to review their results correctly on the BreatheSuite app with no errors

‍

Across these scenarios, these participants continuously demonstrated the usability of the BreatheSuite MDI add-on device and app, as well as determining it could be used to help improve their chronic disease management.

For more information, click below to download our complete white paper!